 BRIDGEWATER, N.J., Oct. 29, 2020 PRNewswire -- Insmed Incorporated Nasdaq: INSM, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the third quarter ended September 30, 2020, and... 